Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Amato

Showing results (61-70 of 330) with videos related to

Pageof 33
Sort By:
Journal of Neurology|November 19, 2025
The brief repeatable battery of neuropsychological test (BRB-N) version B: update of Italian normative dataNicolò Tedone, Marta Grosselle, Emilio Portaccio, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.
Frontiers in Neurology|April 1, 2022
Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple SclerosisMaria Pia Amato, Nicola De Stefano, Matilde Inglese, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2010
Cognitive rehabilitation in children and adolescents with multiple sclerosisEmilio Portaccio, Benedetta Goretti, Valentina Zipoli, et al.
Journal of Neurology|June 6, 2025
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspectiveChiara Zanetta, Claudio Gasperini, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2010
Cognitive impairment in early stages of multiple sclerosisMaria Pia Amato, E Portaccio, B Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2021
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis surveyEmilio Portaccio, Mattia Fonderico, Bernhard Hemmer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Aggressive multiple sclerosis (2): TreatmentGeorgina Arrambide, Ellen Iacobaeus, Maria Pia Amato, et al.
Clinical Kidney Journal|October 6, 2017
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumabMarco Allinovi, Calogero Lino Cirami, Leonardo Caroti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2017
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshopMaria Pia Amato, Tobias Derfuss, Bernard Hemmer, et al.
Pageof 33

Showing results (61-70 of 330) with videos related to

Sort By:
Pageof 33
Journal of Neurology|November 19, 2025
The brief repeatable battery of neuropsychological test (BRB-N) version B: update of Italian normative dataNicolò Tedone, Marta Grosselle, Emilio Portaccio, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.
Frontiers in Neurology|April 1, 2022
Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple SclerosisMaria Pia Amato, Nicola De Stefano, Matilde Inglese, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2010
Cognitive rehabilitation in children and adolescents with multiple sclerosisEmilio Portaccio, Benedetta Goretti, Valentina Zipoli, et al.
Journal of Neurology|June 6, 2025
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspectiveChiara Zanetta, Claudio Gasperini, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2010
Cognitive impairment in early stages of multiple sclerosisMaria Pia Amato, E Portaccio, B Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2021
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis surveyEmilio Portaccio, Mattia Fonderico, Bernhard Hemmer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Aggressive multiple sclerosis (2): TreatmentGeorgina Arrambide, Ellen Iacobaeus, Maria Pia Amato, et al.
Clinical Kidney Journal|October 6, 2017
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumabMarco Allinovi, Calogero Lino Cirami, Leonardo Caroti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2017
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshopMaria Pia Amato, Tobias Derfuss, Bernard Hemmer, et al.
Pageof 33